A COVID-19 vaccine may receive emergency use authorization before phase 3 trials end, said Food and Drug Administration commissioner Stephen Hahn. He stressed that the decision would be based on science and data, not politics. (CNBC)

Most Americans believe the COVID-19 vaccine approval is being driven by politics, according to a STAT and Harris Poll survey. About 78% believe the vaccine is being driven by politics instead of science, with 72% of Republicans and 82% of Democrats expressing concern. (STAT)

Aimmune Therapeutics will be acquired by Nestle. Aimmune, maker of the peanut allergy treatment, will be acquired for $2.6 billion. Nestle is seeking to expand its health sciences unit with the deal. (STAT)

Mylan launched a biosimilar version of insulin as criticism continues over the cost of the drug. Mylan’s drug is a biosimilar of branded insulin Lantus. The company said it is priced 65% less than comparable treatments. (STAT)

GlaxoSmithKline and Vir have begun testing their COVID-19 treatment. The antibody treatment will be tested on recently diagnosed high-risk patients for its ability to prevent hospitalization. (Reuters)